Literature DB >> 1910582

Lysosomal and plasma membrane ganglioside GM3 sialidases of cultured human fibroblasts. Differentiation by detergents and inhibitors.

H R Schneider-Jakob1, M Cantz.   

Abstract

Cultured human fibroblasts contain two sialidases that degrade gangliosides such as GM3: a lysosomal activity that appears identical with the activity towards water-soluble substrates and that is deficient in the genetic lysosomal disorder sialidosis, and another enzyme that seems localized on the external surface of the plasma membrane. In this report we show that both enzymes can be differentiated in the presence of each other by choice of the detergent used for activation, and also by the inhibitory action of some polyanionic compounds such as sulphated glycosaminoglycans. The lysosomal ganglioside GM3 sialidase is greatly stimulated by sodium glycodeoxycholate and, to lesser degrees, by sodium glycocholate and sodium cholate. The ganglioside GM3 sialidase of the plasma membrane is not measurably active under the conditions of the lysosomal enzyme but is specifically activated by the non-ionic detergent Triton X-100. The glycodeoxycholate-stimulated, but not the Triton-activated, ganglioside GM3 sialidase activity was profoundly diminished in cell lines from patients with the lysosomal disorders sialidosis and galactosialidosis; however, both activities were normal in fibroblasts from patients with mucolipidosis IV, previously thought to be a ganglioside sialidase deficiency disorder. Both the lysosomal and the plasma membrane ganglioside GM3 sialidases were inhibited by sialic acids, suramin, dextran sulphate and sulphated glycosaminoglycans. Among the latter, heparin and heparan sulphate showed a much higher inhibitory potency towards the plasma membrane ganglioside GM3 sialidase than towards the lysosomal onw.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1910582     DOI: 10.1515/bchm3.1991.372.1.443

Source DB:  PubMed          Journal:  Biol Chem Hoppe Seyler        ISSN: 0177-3593


  10 in total

Review 1.  Remodeling of sphingolipids by plasma membrane associated enzymes.

Authors:  Massimo Aureli; Nicoletta Loberto; Vanna Chigorno; Alessandro Prinetti; Sandro Sonnino
Journal:  Neurochem Res       Date:  2010-12-23       Impact factor: 3.996

2.  Identifying selective inhibitors against the human cytosolic sialidase NEU2 by substrate specificity studies.

Authors:  Yanhong Li; Hongzhi Cao; Hai Yu; Yi Chen; Kam Lau; Jingyao Qu; Vireak Thon; Go Sugiarto; Xi Chen
Journal:  Mol Biosyst       Date:  2011-01-04

3.  Molecular mechanism of lysosomal sialidase deficiency in galactosialidosis involves its rapid degradation.

Authors:  M V Vinogradova; L Michaud; A V Mezentsev; K E Lukong; M El-Alfy; C R Morales; M Potier; A V Pshezhetsky
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

4.  Evaluation of Disease Lesions in the Developing Canine MPS IIIA Brain.

Authors:  Leanne K Winner; Neil R Marshall; Robert D Jolly; Paul J Trim; Stephen K Duplock; Marten F Snel; Kim M Hemsley
Journal:  JIMD Rep       Date:  2018-06-20

5.  Gangliosides and Cell Surface Ganglioside Metabolic Enzymes in the Nervous System.

Authors:  Massimo Aureli; Laura Mauri; Emma Veronica Carsana; Dorina Dobi; Silvia Breviario; Giulia Lunghi; Sandro Sonnino
Journal:  Adv Neurobiol       Date:  2023

6.  Freeze-stable sialidase activity in human leucocytes: substrate specificity, inhibitor susceptibility, detergent requirements and subcellular localization.

Authors:  P J Waters; A P Corfield; R Eisenthal; C A Pennock
Journal:  Biochem J       Date:  1994-08-01       Impact factor: 3.857

7.  Significant inhibition of hybridoma cells by exogenous application of ganglioside GM3, a possible modulator of cell growth in vitro.

Authors:  H Brandt; J Müthing; J Peter-Katalinić; J Lehmann
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

8.  Cell-contact mediated modulation of the sialylation of contactinhibin.

Authors:  R J Wieser; C E Baumann; F Oesch
Journal:  Glycoconj J       Date:  1995-10       Impact factor: 2.916

9.  A dual drug regimen synergistically blocks human parainfluenza virus infection.

Authors:  Benjamin Bailly; Larissa Dirr; Ibrahim M El-Deeb; Ralf Altmeyer; Patrice Guillon; Mark von Itzstein
Journal:  Sci Rep       Date:  2016-04-07       Impact factor: 4.379

10.  Implications for the mammalian sialidases in the physiopathology of skeletal muscle.

Authors:  Alessandro Fanzani; Alessandra Zanola; Fiorella Faggi; Nadia Papini; Bruno Venerando; Guido Tettamanti; Maurilio Sampaolesi; Eugenio Monti
Journal:  Skelet Muscle       Date:  2012-11-01       Impact factor: 4.912

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.